Effects of Metformin in Pre-frail Elderly

Pre-frail Elderly Clinical Trial

Official title:
Randomized-Controlled Trial of Metformin to Prevent Frailty in Pre-frail Elderly

Status Recruiting

Clinical Trial Summary

The purpose of this study is to investigate the effects of metformin to prevent frailty in pre-frail non-diabetic elderly. Several outcomes measured in this study are frailty status, quality of life, handgrip strength, gait speed, and serum myostatin levels.

We hypothesize that metformin for 16 weeks could prevent frailty in pre-frail elderly.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pre-frail Elderly

Clinical Trial Details

NCT number	NCT02325245
Study type	Interventional
Source	Indonesia University
Contact
Status	Recruiting
Phase	Phase 3
Start date	March 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03110419` - Effects of a Multicomponent Training in Pre-frail Elderly	N/A
Recruiting	`NCT04605809` - Effects of Combined Motor and Cognitive Training in Pre-frail Elderly	N/A
Recruiting	`NCT02753582` - The Effect of SOD Enzyme on Frailty and HRQOL Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial	Phase 4
Completed	`NCT01868945` - Dose Finding Study in Physically Frail Elderly to Measure 25(OH) Vitamin D Levels After Supplementation With Hy.D Calcifediol 25 SD/S and Vitamin D3	Phase 1
Completed	`NCT04847947` - The Effect of Cholecalciferol in Pre-frail Elderly	Phase 3